Biotech company agrees to pay $4 million to settle data falsification allegations
A biotech company whose CEO faced allegations of manipulating data in papers used in NIH grant applications will pay a settlement of $4 million to resolve those allegations, the Department of Justice announced January 6. The settlement is the latest installment in a series of allegations surrounding research by Leen Kawas, the former CEO of … Continue reading Biotech company agrees to pay $4 million to settle data falsification allegations